These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Medical innovation. Patents and confidentiality]. Laccourreye O; Sezeur A; Cauchois R; Rodhain C Ann Otolaryngol Chir Cervicofac; 1993; 110(3):173-6. PubMed ID: 8239339 [TBL] [Abstract][Full Text] [Related]
3. Secrecy in research. Lu B N Engl J Med; 1996 Jul; 335(2):135; author reply 135-6. PubMed ID: 8649485 [No Abstract] [Full Text] [Related]
4. Secrecy in medical research. Rosenberg SA N Engl J Med; 1996 Feb; 334(6):392-4. PubMed ID: 8538713 [No Abstract] [Full Text] [Related]
5. Patent pending. The challenges of bringing an invention to market. Goldman PM Minn Med; 1999 Sep; 82(9):29-31. PubMed ID: 10510615 [No Abstract] [Full Text] [Related]
6. Clearing a path through the patent thicket. Holman C Cell; 2006 May; 125(4):629-33. PubMed ID: 16713553 [TBL] [Abstract][Full Text] [Related]
7. [Self-interest can be of benefit for everyone and save medical research]. Fändriks L; Edén S Lakartidningen; 2001 Jun; 98(26-27):3146-9. PubMed ID: 11478213 [No Abstract] [Full Text] [Related]
8. Establishing novelty and relevant prior art. Murphy C Nat Rev Drug Discov; 2004 Jul; 3(7):545. PubMed ID: 15272495 [No Abstract] [Full Text] [Related]
9. Patents and the research exemption. Resnik DB Science; 2003 Feb; 299(5608):821-2. PubMed ID: 12574602 [No Abstract] [Full Text] [Related]
10. Much ado about gene patents: the role of foreseeability. Gulliford MJ Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032 [No Abstract] [Full Text] [Related]
11. Ownership of knowledge--the role of patents in pharmaceutical R&D. Correa CM Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801 [TBL] [Abstract][Full Text] [Related]
12. Gene patent policy: does issuing gene patents accord with the purposes of the U.S. patent system? Bradshaw J Willamette Law Rev; 2001; 37(4):637-60. PubMed ID: 12774776 [No Abstract] [Full Text] [Related]
14. [Valuation of innovation: a new challenge for the structures of care, an opportunity for everybody...]. Sezeur A J Mal Vasc; 2010 Feb; 35(1):1-3. PubMed ID: 20042305 [No Abstract] [Full Text] [Related]
15. A general approach for determining when to patent, publish, or protect information as a trade secret. Daizadeh I; Miller D; Glowalla A; Leamer M; Nandi R; Numark CI Nat Biotechnol; 2002 Oct; 20(10):1053-4. PubMed ID: 12355117 [No Abstract] [Full Text] [Related]
16. Contrary to first impression, genes are patentable: should there be limitations? Pitcher AS J Health Care Law Policy; 2003; 6(2):284-303. PubMed ID: 15017959 [No Abstract] [Full Text] [Related]
17. [Commercialization of genetic research and its impact on the communication of results]. Cardinal G Health Law J; 1999; 7():35-48, 33. PubMed ID: 11066367 [TBL] [Abstract][Full Text] [Related]
18. What's holding us back? Understanding barriers to innovation in academic neurosurgery. Leuthardt EC Surg Neurol; 2006 Oct; 66(4):347-9; discussion 349. PubMed ID: 17015102 [No Abstract] [Full Text] [Related]
19. Science and the law. Patent swords and shields. Eisenberg RS Science; 2003 Feb; 299(5609):1018-9. PubMed ID: 12586927 [No Abstract] [Full Text] [Related]
20. Realizing two-tiered innovation policy through drug regulation. Ridgway WE Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807 [No Abstract] [Full Text] [Related] [Next] [New Search]